Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28(3):583–90.
The Lancet Public H. COVID-19 pandemic: what’s next for public health? Lancet Public Health. 2022;7(5):e391.
Wang W, Wang CY, Wang SI, Wei JC. Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: a retrospective cohort study from the TriNetX US collaborative networks. EClinicalMedicine. 2022;53:101619.
Raman B, Bluemke DA, Luscher TF, Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J. 2022;43(11):1157–72.
Terzic CM, Medina-Inojosa BJ. Cardiovascular complications of coronavirus disease-2019. Phys Med Rehabil Clin N Am. 2023;34(3):551–61.
Fairweather D, Beetler DJ, Di Florio DN, Musigk N, Heidecker B, Cooper LT Jr. COVID-19, myocarditis and pericarditis. Circ Res. 2023;132(10):1302–19.
Huseynov A, Akin I, Duerschmied D, Scharf RE. Cardiac arrhythmias in post-COVID syndrome: prevalence, pathology, diagnosis, and treatment. Viruses. 2023;15(2):389.
Patone M, Mei XW, Handunnetthi L, Dixon S, Zaccardi F, Shankar-Hari M, Watkinson P, Khunti K, Harnden A, Coupland CAC, et al. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat Med. 2022;28(2):410–22.
Wrona M, Skrypnik D. New-onset diabetes mellitus, hypertension, dyslipidaemia as sequelae of COVID-19 infection-systematic review. Int J Environ Res Public Health. 2022;19(20):13280.
Izzo R, Pacella D, Trimarco V, Manzi MV, Lombardi A, Piccinocchi R, Gallo P, Esposito G, Lembo M, Piccinocchi G, et al. Incidence of type 2 diabetes before and during the COVID-19 pandemic in Naples, Italy: a longitudinal cohort study. EClinicalMedicine. 2023;66:102345.
Mone P, Jankauskas SS, Manzi MV, Gambardella J, Coppola A, Kansakar U, Izzo R, Fiorentino G, Lombardi A, Varzideh F, et al. Endothelial extracellular vesicles enriched in microRNA-34a predict new-onset diabetes in COVID-19 patients: novel insights for long-COVID metabolic sequelae. J Pharmacol Exp Ther. 2024. https://doi.org/10.1124/jpet.122.001253.
Kim SH, Arora I, Hsia DS, Knowler WC, LeBlanc E, Mylonakis E, Pratley R, Pittas AG. New-onset diabetes after COVID-19. J Clin Endocrinol Metab. 2023;108:e1164–74.
Li J, Li Y, Wang Z, Liu N, He L, Zhang H. Increased risk of new-onset diabetes in patients with COVID-19: a systematic review and meta-analysis. Front Public Health. 2023;11:1170156.
Chourasia P, Goyal L, Kansal D, Roy S, Singh R, Mahata I, Sheikh AB, Shekhar R. Risk of new-onset diabetes mellitus as a post-COVID-19 condition and possible mechanisms: a scoping review. J Clin Med. 2023;12(3):1159.
Zhang T, Mei Q, Zhang Z, Walline JH, Liu Y, Zhu H, Zhang S. Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis. BMC Med. 2022;20(1):444.
Zhang V, Fisher M, Hou W, Zhang L, Duong TQ. Incidence of new-onset hypertension post-COVID-19: comparison with influenza. Hypertension. 2023;80(10):2135–48.
Quinn KL, Stukel TA, Huang A, Abdel-Qadir H, Altaf A, Bell CM, Cheung AM, Detsky AS, Goulding S, Herridge M, et al. Comparison of medical and mental health sequelae following hospitalization for COVID-19, influenza, and sepsis. JAMA Intern Med. 2023;183(8):806–17.
Scobie HM, Panaggio M, Binder AM, Gallagher ME, Duck WM, Graff P, Silk BJ. Correlations and timeliness of COVID-19 surveillance data sources and indicators – United States, October 1, 2020-March 22, 2023. MMWR Morb Mortal Wkly Rep. 2023;72(19):529–35.
Cefalu WT. COVID-19 and rising incidence of diabetes: despite evolving data, an enigma still to be solved. Diabetes Care. 2023;46(5):913–5.
Gong F, Wei HX, Li Q, Liu L, Li B. Evaluation and comparison of serological methods for COVID-19 diagnosis. Front Mol Biosci. 2021;8:682405.
Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133–46.
Russo V, Piccinocchi G, Mandaliti V, Annunziata S, Cimmino G, Attena E, Moio N, Di Micco P, Severino S, Trotta R, et al. Cardiovascular comorbidities and pharmacological treatments of COVID-19 patients not requiring hospitalization. Int J Environ Res Public Health. 2020;18(1):102.
Ullah H, Esposito C, Piccinocchi R, De Lellis LF, Santarcangelo C, Minno AD, Baldi A, Buccato DG, Khan A, Piccinocchi G, et al. Postprandial glycemic and insulinemic response by a Brewer’s spent grain extract-based food supplement in subjects with slightly impaired glucose tolerance: a monocentric, randomized, cross-over, double-blind, placebo-controlled clinical trial. Nutrients. 2022;14(19):3916.
Oran DP, Topol EJ. Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review. Ann Intern Med. 2020;173(5):362–7.
Giordano G, Blanchini F, Bruno R, Colaneri P, Di Filippo A, Di Matteo A, Colaneri M. Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy. Nat Med. 2020;26(6):855–60.
Maison D, Jaworska D, Adamczyk D, Affeltowicz D. The challenges arising from the COVID-19 pandemic and the way people deal with them. A qualitative longitudinal study. PLoS One. 2021;16(10):e0258133.
Modesti PA, Wang J, Damasceno A, Agyemang C, Van Bortel L, Persu A, Zhao D, Jarraya F, Marzotti I, Bamoshmoosh M, et al. Indirect implications of COVID-19 prevention strategies on non-communicable diseases: an opinion paper of the European society of hypertension working group on hypertension and cardiovascular risk assessment in subjects living in or emigrating from low resource settings. BMC Med. 2020;18(1):256.
D’Angelo G, Rampone S. Forecasting the spread of SARS-CoV-2 in the campania region using genetic programming. Soft Comput. 2022;26(19):10075–83.
Kobayashi K, Noguchi M. Wearing a mask does indeed matter: lessons from the 2021 influenza infection season. Eur J Intern Med. 2021;91:96–7.
Han S, Zhang T, Lyu Y, Lai S, Dai P, Zheng J, Yang W, Zhou XH, Feng L. Influenza’s plummeting during the COVID-19 pandemic: the roles of mask-wearing, mobility change, and SARS-CoV-2 interference. Engineering (Beijing). 2023;21:195–202.
Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R, Santulli G. Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence. J Clin Med. 2020;9(5):1417.
Busse LW, Chow JH, McCurdy MT, Khanna AK. COVID-19 and the RAAS-a potential role for angiotensin II? Crit Care. 2020;24(1):136.
Cooper SL, Boyle E, Jefferson SR, Heslop CRA, Mohan P, Mohanraj GGJ, Sidow HA, Tan RCP, Hill SJ, Woolard J. Role of the renin-angiotensin-aldosterone and kinin-kallikrein systems in the cardiovascular complications of COVID-19 and long COVID. Int J Mol Sci. 2021;22(15):39164.
Azevedo RB, Botelho BG, Hollanda JVG, Ferreira LVL, Junqueira de Andrade LZ, Oei S, Mello TS, Muxfeldt ES. Covid-19 and the cardiovascular system: a comprehensive review. J Hum Hypertens. 2021;35(1):4–11.
Garcia-Gasalla M, Berman-Riu M, Pons J, Rodriguez A, Iglesias A, Martinez-Pomar N, Llompart-Alabern I, Riera M, Ferre Beltran A, Figueras-Castilla A, et al. Hyperinflammatory state and low T1 adaptive immune response in severe and critical acute COVID-19 patients. Front Med (Lausanne). 2022;9:828678.
Tan LY, Komarasamy TV, Rmt Balasubramaniam V. Hyperinflammatory immune response and COVID-19: a double-edged sword. Front Immunol. 2021;12:742941.
Ning Q, Wu D, Wang X, Xi D, Chen T, Chen G, Wang H, Lu H, Wang M, Zhu L, et al. The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication. Signal Transduct Target Ther. 2022;7(1):57.
Martinez-Pomar N, Cunill V, Segura-Guerrero M, Pol-Pol E, Escobar Oblitas D, Pons J, Ayestaran I, Pruneda PC, Losada I, Toledo-Pons N, et al. Hyperinflammatory immune response in COVID-19: host genetic factors in pyrin inflammasome and immunity to virus in a Spanish population from Majorca Island. Biomedicines. 2023;11(9):2548.
Palmer K, Monaco A, Kivipelto M, Onder G, Maggi S, Michel JP, Prieto R, Sykara G, Donde S. The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing. Aging Clin Exp Res. 2020;32(7):1189–94.
Zieff G, Bates LC, Kerr ZY, Moore JB, Hanson ED, Battaglini C, Stoner L. Targeting sedentary behavior as a feasible health strategy during COVID-19. Transl Behav Med. 2021;11(3):826–31.
Young DR, Sallis JF, Baecker A, Cohen DA, Nau CL, Smith GN, Sallis RE. Associations of physical inactivity and COVID-19 outcomes among subgroups. Am J Prev Med. 2023;64(4):492–502.
Nozato Y, Yamamoto K, Rakugi H. Hypertension management before and under the COVID-19 pandemic: lessons and future directions. Hypertens Res. 2023;46(6):1471–7.
Spruill TM. Chronic psychosocial stress and hypertension. Curr Hypertens Rep. 2010;12(1):10–6.
Kreutz R, Dobrowolski P, Prejbisz A, Algharably EAE, Bilo G, Creutzig F, Grassi G, Kotsis V, Lovic D, Lurbe E, et al. Lifestyle, psychological, socioeconomic and environmental factors and their impact on hypertension during the coronavirus disease 2019 pandemic. J Hypertens. 2021;39(6):1077–89.
Gomez-Escalonilla Lorenzo S, Martinez I, Notario Pacheco B. Influence of COVID-19 on treatment adherence and psychological well-being in a sample of hypertensive patients: a cross-sectional study. BMC Psychiatry. 2023;23(1):121.
Gotanda H, Liyanage-Don N, Moran AE, Krousel-Wood M, Green JB, Zhang Y, Nuckols TK. Changes in blood pressure outcomes among hypertensive individuals during the COVID-19 pandemic: a time series analysis in three US healthcare organizations. Hypertension. 2022;79(12):2733–42.
Kobayashi K, Chin K, Umezawa S, Ito S, Yamamoto H, Nakano S, Takada N, Hatori N, Tamura K. Influence of stress induced by the first announced state of emergency due to coronavirus disease 2019 on outpatient blood pressure management in Japan. Hypertens Res. 2022;45(4):675–85.
Kashihara T, Mukai R, Oka SI, Zhai P, Nakada Y, Yang Z, Mizushima W, Nakahara T, Warren JS, Abdellatif M, et al. YAP mediates compensatory cardiac hypertrophy through aerobic glycolysis in response to pressure overload. J Clin Invest. 2022;132(6):e150595.
Murphy C, Lim WW, Mills C, Wong JY, Chen D, Xie Y, Li M, Gould S, Xin H, Cheung JK, et al. Effectiveness of social distancing measures and lockdowns for reducing transmission of COVID-19 in non-healthcare, community-based settings. Philos Trans A Math Phys Eng Sci. 2023;381(2257):20230132.
Gao W, Sanna M, Chen YH, Tsai MK, Wen CP. Occupational sitting time, leisure physical activity, and all-cause and cardiovascular disease mortality. JAMA Netw Open. 2024;7(1):e2350680.
Add Comment